Literature DB >> 7693433

Propiram. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use as an analgesic.

Karen L Goa1, Rex N Brogden1.   

Abstract

Propiram is an orally administered opioid analgesic with partial morphine-like agonist and weak antagonist properties. Analgesic efficacy of propiram, usually 50 or 100mg, appears comparable to that of standard dosages of other oral opioid drugs [i.e. pentazocine, pethidine (meperidine)] in patients with acute pain of moderate to severe intensity arising from various gynaecological and surgical procedures, and may be superior to codeine in gynaecological and postoperative dental pain. Some evidence of a more rapid onset of action for propiram than for these opioid agents, and a longer duration of action for propiram than for codeine, is encouraging but remains to be substantiated in more extensive clinical use. The tolerability profile of propiram resembles those of others in its class, with drowsiness, nausea and vomiting, and dizziness experienced most frequently in controlled trials. The apparently low propensity of propiram for development of physical dependence and psychotomimetic effects requires confirmation with wider clinical experience. Available data thus indicate that propiram is an effective, orally administered opioid analgesic suitable for providing relief of acute moderate to severe pain arising from various surgical or gynaecological procedures, and that the drug is likely to become a useful alternative in such conditions where opioid analgesia is appropriate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693433     DOI: 10.2165/00003495-199346030-00008

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  41 in total

1.  The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog.

Authors:  P E Gilbert; W R Martin
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

2.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

3.  [Effect of the new analgesic propiramfumarate on respiration].

Authors:  H Lennartz; U Drechsel
Journal:  Arzneimittelforschung       Date:  1974-04

4.  [Blood circulation and ECG under the effect of propiramfumarate. Results of a double blind study].

Authors:  W Kollert; R Hullmann; J Sommer
Journal:  Arzneimittelforschung       Date:  1974-04

5.  [Administration of propiramfumarate in obstretics].

Authors:  C F Michel
Journal:  Arzneimittelforschung       Date:  1974-04

6.  Combined routes of administration to assay oral analgesia in postoperative pain.

Authors:  W H Forrest; C R Brown; J Katz; D L Mahler; P F Shroff; G Teutsch; K E James; B W Brown
Journal:  J Clin Pharmacol       Date:  1976 Nov-Dec       Impact factor: 3.126

7.  Negative reinforcing properties of morphine-antagonists in naive rhesus monkeys.

Authors:  F Hoffmeister; W Wuttke
Journal:  Psychopharmacologia       Date:  1973

8.  Reinforcing properties of some opiates and opioids in rhesus monkeys with histories of cocaine and codeine self-administration.

Authors:  F Hoffmeister; U U Schlichting
Journal:  Psychopharmacologia       Date:  1972

9.  The relative analgesic efficacy of propiram fumarate, codeine, aspirin, and placebo in post-impaction dental pain.

Authors:  P J Desjardins; S A Cooper; T L Gallegos; J B Allwein; D C Reynolds; G O Kruger; W T Beaver
Journal:  J Clin Pharmacol       Date:  1984-01       Impact factor: 3.126

10.  Propiram and codeine in episiotomy pain.

Authors:  S S Bloomfield; T P Barden; J Mitchell
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1981-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.